Atlas Trials

Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate

Clinical trial NCT02889796 · COMPLETED

Trial details

NCT number
NCT02889796
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2016-08-30
Primary completion
2018-07-04
Enrollment
1759

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.